CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-11.4%/yr
vs +6.3%/yr prior
5Y CAGR
-3.7%/yr
Recent deceleration
Acceleration
-17.7pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $29.80M | +0.2% |
| 2024 | $29.73M | -1.0% |
| 2023 | $30.02M | -29.9% |
| 2022 | $42.85M | +9.4% |
| 2021 | $39.16M | +8.7% |
| 2020 | $36.03M | -2.0% |
| 2019 | $36.77M | +9.7% |
| 2018 | $33.51M | +30.9% |
| 2017 | $25.61M | +28.8% |
| 2016 | $19.87M | - |